Filed: 7/27/2023ACC: 0000950123-23-006361
📋 What this filing means
SYNCONA PORTFOLIO LTD filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $66.34M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$66.34M
Total AUM (reported)
35.28M
Total Shares
Allocation by class
SPON ADS$50.81M76.6%
SPONSORED ADS$14.26M21.5%
SPONDS ADR$1.27M1.9%
Portfolio Concentration
Top 3$65.07M98.1%
4–10$1.27M1.9%
Top 3 weight
98.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 35.28M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
35.28M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other4
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings4
Rows:
AUTOLUS THERAPEUTICS PLC
OTRShares21.35M
TypeSH
Market value$50.81M
76.58%
Sole
0.00
Shared
21.35M
None
0.00
ACHILLES THERAPEUTICS PLC
OTRShares11.09M
TypeSH
Market value$10.48M
15.80%
Sole
0.00
Shared
11.09M
None
0.00
FREELINE THERAPEUTICS HLDGS
OTRShares1.47M
TypeSH
Market value$3.78M
5.70%
Sole
0.00
Shared
1.47M
None
0.00
ADAPTIMMUNE THERAPEUTICS PLC
OTRShares1.38M
TypeSH
Market value$1.27M
1.92%
Sole
0.00
Shared
1.38M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLCOTR | SPON ADS | 21.35M | SH | $50.81M 76.58% | 0.00 | 21.35M | 0.00 |
ACHILLES THERAPEUTICS PLCOTR | SPONSORED ADS | 11.09M | SH | $10.48M 15.80% | 0.00 | 11.09M | 0.00 |
FREELINE THERAPEUTICS HLDGSOTR | SPONSORED ADS | 1.47M | SH | $3.78M 5.70% | 0.00 | 1.47M | 0.00 |
ADAPTIMMUNE THERAPEUTICS PLCOTR | SPONDS ADR | 1.38M | SH | $1.27M 1.92% | 0.00 | 1.38M | 0.00 |